Dr. Richard M. Breyer is a biochemist and a Professor of Medicine at Vanderbilt University Medical Center. Dr. Breyer’s research interests focus on the pharmacology and physiology of prostaglandins and prostaglandin receptors. Specifically, he is interested in determining the role of E-prostanoid receptors in disease states, including Alzheimer’s disease. Dr. Breyer is an investigator in the Vanderbilt Alzheimer’s Disease Research Center.
Dr. Breyer completed a master’s degree in biology at Massachusetts Institute of Technology, a doctoral degree in biochemistry at Massachusetts Institute of Technology, and postdoctoral fellowships in pharmacology at Biologie Moléculaire des Récepteurs and Laboratoire d’Immuno-Pharmacologie Moléculaire. He joined the Vanderbilt faculty in 1991.